Ashley Garrett
Family · Saint Louis, MONPI 1275077034
Payments from drug & device makers
Across 762 payments — averaging $15.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$3K
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$1K
- Johnson & Johnson$859
- Takeda Pharmaceuticals U.S.A., Inc.$851
- Pfizer$834
- Gilead$683
- plus $4K from 29 others
What the payments were for
- Food & beverage$12,101100%
- Education$310%
- Gifts$120%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 224 | $3,397 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 82 | $1,488 |
| Johnson & Johnson(2 entities) | 50 | $859 |
| Takeda Pharmaceuticals U.S.A., Inc. | 56 | $851 |
| Pfizer | 60 | $834 |
| Gilead | 47 | $683 |
| Bristol Myers Squibb | 54 | $522 |
| Amgen | 23 | $492 |
| Sanofi | 16 | $387 |
| Lilly USA, LLC | 15 | $290 |
| QOL Medical, LLC | 14 | $286 |
| Aimmune Therapeutics, Inc. | 14 | $231 |
| Merck | 12 | $212 |
| Intercept Pharmaceuticals, Inc. | 13 | $209 |
| Ardelyx, Inc. | 12 | $208 |
| Nestle Healthcare Nutrition Inc. | 12 | $192 |
| Ironwood Pharmaceuticals, Inc | 9 | $168 |
| Redhill Biopharma Inc. | 8 | $125 |
| Celltrion USA Inc. | 6 | $98 |
| Regeneron Healthcare Solutions, Inc. | 4 | $93 |
| Madrigal Pharmaceuticals | 5 | $81 |
| Ferring Pharmaceuticals Inc. | 4 | $65 |
| Phathom Pharmaceuticals, Inc. | 4 | $60 |
| Daiichi Sankyo Inc. | 3 | $45 |
| Organon | 2 | $44 |
| Pharmacosmos Therapeutics Inc. | 2 | $39 |
| Braintree Laboratories, Inc. | 2 | $30 |
| Fresenius Kabi USA, LLC | 2 | $29 |
| Alnylam Pharmaceuticals Inc. | 1 | $25 |
| AMAG Pharmaceuticals, Inc. | 1 | $19 |
| Boehringer Ingelheim | 1 | $19 |
| Polynovo North America LLC | 1 | $19 |
| Exact Sciences | 1 | $16 |
| Medtronic | 1 | $15 |
| Sandoz | 1 | $14 |
How this compares
$12,144 in reported general payments places this provider in the 95th percentile of 3,812 family providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| CreonLipase/Protease/Amylase | 25 | $72,878 |
| Mesalamine | 111 | $55,524 |
| LinzessLinaclotide | 70 | $47,718 |
| IbsrelaTenapanor Hcl | 17 | $29,153 |
| MotegrityPrucalopride Succinate | 26 | $23,371 |
| Mesalamine ErMesalamine | 81 | $19,753 |
| TrulancePlecanatide | 27 | $14,612 |
| Dexlansoprazole DrDexlansoprazole | 30 | $8,970 |
| Ursodiol | 39 | $7,016 |
| Balsalazide Disodium | 36 | $6,079 |
| Azathioprine | 27 | $5,856 |
| Lubiprostone | 27 | $5,695 |
| Cholestyramine LightCholestyramine | 48 | $3,907 |
| Famotidine | 244 | $3,879 |
| Pantoprazole Sodium | 311 | $3,838 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieCreon, Linzess | $3,397 | $120,59695 claims |
| Ardelyx, Inc.Ibsrela | $208 | $29,15317 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Motegrity | $851 | $23,37126 claims |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCTrulance | $1,488 | $14,61227 claims |
| SandozLansoprazole | $14 | $1,95775 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,812 family providers in Missouri.
Other family in Saint Louis
- Rebecca SeabaughSaint Louis$68K
- Jordan PerezSaint Louis$43K
- Lindsay GwaltneySaint Louis$28K
- Sara WoottenSaint Louis$21K
- Kelly RobertsSaint Louis$17K
- Matthew CarySaint Louis$15K
- Philip DudakSaint Louis$14K
- Kenan SahbazSaint Louis$14K
- Nicole CarrSaint Louis$14K
- Monica SanchezSaint Louis$12K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.